Daniel Grosslight
Stock Analyst at Citigroup
(1.30)
# 3,324
Out of 4,829 analysts
94
Total ratings
35.59%
Success rate
-11.29%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $51.96 | -42.26% | 11 | May 6, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $7 → $6.5 | $4.13 | +57.38% | 9 | Apr 25, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $7.11 | +23.07% | 11 | Apr 25, 2025 | |
| AGL agilon health | Upgrades: Buy | $3.25 → $5 | $2.89 | +73.01% | 5 | Apr 25, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $13 → $11 | $7.01 | +56.92% | 6 | Apr 17, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $120 → $129 | $148.22 | -12.97% | 5 | Jan 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $9.05 | +98.90% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.32 | +44.68% | 7 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $693.46 | -2.37% | 7 | Jan 10, 2025 | |
| PHR Phreesia | Maintains: Buy | $31 → $35 | $25.62 | +36.61% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $25.02 | -0.08% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $5.12 | +95.31% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $10.02 | -20.16% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.67 | -53.18% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.02 | +15.89% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $8.58 | +51.60% | 1 | Dec 11, 2019 |
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $51.96
Upside: -42.26%
Health Catalyst
Apr 25, 2025
Maintains: Buy
Price Target: $7 → $6.5
Current: $4.13
Upside: +57.38%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $7.11
Upside: +23.07%
agilon health
Apr 25, 2025
Upgrades: Buy
Price Target: $3.25 → $5
Current: $2.89
Upside: +73.01%
Owens & Minor
Apr 17, 2025
Maintains: Buy
Price Target: $13 → $11
Current: $7.01
Upside: +56.92%
Cardinal Health
Jan 10, 2025
Maintains: Neutral
Price Target: $120 → $129
Current: $148.22
Upside: -12.97%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $9.05
Upside: +98.90%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.32
Upside: +44.68%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $693.46
Upside: -2.37%
Phreesia
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $25.62
Upside: +36.61%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $25.02
Upside: -0.08%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $5.12
Upside: +95.31%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $10.02
Upside: -20.16%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.67
Upside: -53.18%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.02
Upside: +15.89%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $8.58
Upside: +51.60%